These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20818365)

  • 1. Diabetes mellitus, obesity, and hepatocellular carcinoma: the jury is still out.
    Shebl FM; El-Kamary SS
    Am J Gastroenterol; 2010 Sep; 105(9):2116-7. PubMed ID: 20818365
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 2 diabetes does not worsen prognosis in hepatocellular carcinoma.
    Howell J; Yiu M; Gibson R; Thomson B; Stella D; Gorelik A; Prichard PJ; Nicoll AJ
    Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):214-20. PubMed ID: 21501980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
    Mori S; Yamasaki T; Sakaida I; Takami T; Sakaguchi E; Kimura T; Kurokawa F; Maeyama S; Okita K
    J Gastroenterol; 2004; 39(4):391-6. PubMed ID: 15168253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Right-side abdominal pain, weight loss].
    Marolf A; Hany S; Vetter W
    Schweiz Rundsch Med Prax; 1986 Dec; 75(49):1509-12. PubMed ID: 3025991
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder.
    Ikeda H; Suzuki M; Takahashi H; Kobayashi M; Okuse N; Moriya H; Koike J; Maeyama S; Yotsuyanagi H; Itoh F
    Pathol Int; 2006 Jan; 56(1):40-5. PubMed ID: 16398679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: steatosis, the metabolic syndrome and cancer.
    Bugianesi E
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatosis and hepatocellular carcinoma risk.
    Smedile A; Bugianesi E
    Eur Rev Med Pharmacol Sci; 2005; 9(5):291-3. PubMed ID: 16231592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and primary hepatocellular carcinoma.
    Lawson DH; Gray JM; McKillop C; Clarke J; Lee FD; Patrick RS
    Q J Med; 1986 Oct; 61(234):945-55. PubMed ID: 2819932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
    Ratziu V; Bonyhay L; Di Martino V; Charlotte F; Cavallaro L; Sayegh-Tainturier MH; Giral P; Grimaldi A; Opolon P; Poynard T
    Hepatology; 2002 Jun; 35(6):1485-93. PubMed ID: 12029634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index in type 2 diabetes mellitus complications: hypertensive diabetics and diabetic nephropathy.
    Idogun ES; Unuigbe EI; Famodu AA; Akinola OT
    Niger Postgrad Med J; 2006 Mar; 13(1):17-20. PubMed ID: 16633373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma.
    Poon RT
    Am J Gastroenterol; 2004 Aug; 99(8):1488-9. PubMed ID: 15307865
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of ruptured hepatocellular carcinoma (HCC) in resolving non-alcoholic steatohepatitis associated with type 2 diabetes: Is early detection of diabetes-related HCC feasible?
    Ikura Y; Tiniakos DG; Tanaka T; Harada K
    J Diabetes; 2017 Mar; 9(3):311-313. PubMed ID: 27754600
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes and hepatocellular carcinoma.
    Beasley RP
    Hepatology; 2006 Dec; 44(6):1408-10. PubMed ID: 17133479
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
    J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of diabetes mellitus on hepatocellular carcinoma].
    Taura N; Ichikawa T; Miuma S; Nakao K
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():566-72. PubMed ID: 23156460
    [No Abstract]   [Full Text] [Related]  

  • 17. The skinny on fat.
    Goldie MP
    Int J Dent Hyg; 2010 May; 8(2):150-2. PubMed ID: 20522140
    [No Abstract]   [Full Text] [Related]  

  • 18. Obesity and diabetes as a risk factor for hepatocellular carcinoma.
    Regimbeau JM; Colombat M; Mognol P; Durand F; Abdalla E; Degott C; Degos F; Farges O; Belghiti J
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity.
    Xu KZ; Zhu C; Kim MS; Yamahara J; Li Y
    J Ethnopharmacol; 2009 Jun; 123(2):280-7. PubMed ID: 19429373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.